Friday, May 27 2022

LAS VEGAS and VANCOUVER, British Columbia, March 30, 2022 (GLOBE NEWSWIRE) — TAAT® GLOBAL ALTERNATIVES INC. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) (the “Company” or “TAAT®”) is pleased to announce that it has accepted an invitation from the multinational investment bank Jefferies Group (“Jefferies”) to present to the Jefferies Cannabis Summit Thursday, June 2, 2022 (revised from the original date of Wednesday, March 2, 2022). Taking place at the InterContinental Barclay in New York, the Jefferies Cannabis Summit is a one-day live event with global virtual attendance options where cannabis industry players will present their respective corporate presentations and participate in individual meetings. The Jefferies Cannabis Summit is an invitation-only event, attended exclusively by Jefferies clients who are mostly institutional equity investors. Although TAAT® is primarily positioned in the US$812 billion global tobacco industry, its use of hemp in the tobacco-free and nicotine-free Beyond Tobaccoâ„¢ base material allows the company to participate in this event.

In 2021, Jefferies launched coverage of seven cannabis companies in the United States, assigning a “Buy” rating to each, describing this as a potential “generational wealth opportunity” in a report to its clients. At the same time, Jefferies estimated that the U.S. cannabis sector will grow at a rate of 14% from 2020 to 2030. Jefferies said he believes a limiting factor in the valuation of U.S. cannabis companies is the lack institutional support. According to his estimates, Jefferies calculated institutional ownership of US cannabis company stocks at 4%, compared to 15% for the Canadian cannabis space.1.

For more information about Jefferies, please visit the following website: http://jefferies.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/58757a27-ddb9-4a3f-9e2f-c330c0f0d73f

On Thursday, June 2, 2022, TAAT® will present at the Jefferies Cannabis Summit; an invitation-only event for clients of Jefferies (a multinational investment bank), who are mostly institutional equity investors. Following the company’s presentation to investors, individual attendees can participate in one-on-one meetings with TAAT® to learn more about the company and its journey to capturing market share in the $812 billion global tobacco industry. U.S. dollars. The current version of the TAAT® investor presentation is accessible by click here.

Readers using news aggregation services may not be able to view the above media. Please access SEDAR or Investor Relations section of the Company’s website for a version of this press release containing all published media.

TAAT® Founder Joe Deighan said, “We are grateful to have been invited to the Jefferies Cannabis Summit in New York, as it confirms us as a leading name in a space that Jefferies is clearly very excited about. . The reach of the cannabis industry is immense, and our new approach to leveraging hemp as a base material for a nicotine-free, tobacco-free alternative to tobacco cigarettes is a testament to the versatility of its biomass. I see this as a very unique opportunity for us, as institutional investors make up a significant share of the major tobacco company shareholders (for examplemore than 75% of the shares of Philip Morris International are held by more than 2,400 different institutions2), and putting TAAT® in front of an audience of institutional investors could be extremely beneficial to us as we seek to grow and strengthen our profile in the capital markets.

Sources

1 – https://www.bnnbloomberg.ca/jefferies-initiates-coverage-on-us-pot-operators-with-bullish-view-on-us-market-1.1626287

2 – https://finance.yahoo.com/quote/PM/holders?p=PM (data from Tuesday March 29, 2022)

On behalf of the Company’s Board of Directors,

TAAT® GLOBAL ALTERNATIVES INC.

Setti Coscarella

Setti Coscarella, CEO and Director

For more information, please contact:

TAAT® Investor Relations
1-833-TAAT-USA (1-833-822-8872)
[email protected]

THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR SUITABILITY OF THIS RELEASE, NOR HAS NOR THE CSE’S REGULATORY SERVICE PROVIDER.

About TAAT® Global Alternatives Inc.

The Company has developed TAAT®, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original”, “Smooth” and “Menthol” varieties. The base material of TAAT® is Beyond Tobaccoâ„¢, a proprietary blend that undergoes a patent-pending refinement technique that causes its scent and taste to resemble tobacco. Under the direction of management with the “Big Tobacco” pedigree, TAAT® was first launched in the United States in the fourth quarter of 2020 as the company seeks to position itself on the 812 billion dollars1 the global tobacco industry.

For more information, please visit http://taatglobal.com.

The references

1 Statista: Consumer Markets – Tobacco Products

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates “, “intends to”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or declare that certain actions, events or results “could”, “might” , “would”, “could” or “will” occur, occur or be achieved. The forward-looking information in this press release includes statements regarding the anticipated performance of TAAT® in the tobacco industry, in addition to following: Occurrence of the Jefferies Cannabis Summit event on June 2, 2022, TAAT®’s participation in the event (whether virtually or live), potential results of the company’s presentation and attendance at the Jefferies Cannabis Summit. Forward-looking information reflects expectations of management based on currently available information and are subject to a number of risks and uncertainties that may cause actual results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur within the time periods disclosed or not. at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of tobacco markets; and (iii) other factors beyond the Company’s control. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, could cause actual results to differ from those contained in the forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , except as required by applicable law.

The statements in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or warranty can be made as to the effects of the Company’s products on the health and well-being of any individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third-party entities (or their respective offerings with brand names) generally in reference to (i) the Company’s relationships with the third-party entities mentioned in this press release and/or (ii ) customers/suppliers/service providers whose relationship with the Company is/are mentioned in this press release. All rights in and to these marks are reserved by their respective owners or licensees.

Statement Regarding Third-Party Investor Relations Firms

Information about the investor relations firms retained by TAAT® Global Alternatives Inc. can be found under the company profile on http://sedar.com.

Previous

ECHO Incorporated launches new website

Next

Apple opens website payment to Spotify, Netflix, etc. : result of Japan Fair Trade Commission settlement

Check Also